This is a routine director participation notice in a pre-approved securities purchase plan. No immediate trading catalyst. Monitor upcoming clinical or regulatory milestones for the company's radiopharmaceutical pipeline.
Price Chart
Executive Summary
Radiopharm Theranostics filed a Form 6-K with the SEC on September 22, 2026, disclosing that four directors (Bruce Goodwin, Ian Turner, Paul Hopper, and Riccardo Canevari) acquired shares and listed options via a Securities Purchase Plan approved at an EGM on September 11, 2026. The directors collectively acquired approximately 11.2 million fully paid ordinary shares at A$0.009 per share, along with matching listed options exercisable at A$0.018 through July 2029. This is a routine director participation notice with no material financial impact on the company.
Key Facts
- Four directors acquired shares via a Securities Purchase Plan approved at an EGM on September 11, 2026.
- Bruce Goodwin acquired 2,777,778 shares and 2,777,778 options (indirect) for A$25,000.
- Ian Turner acquired 2,777,778 shares and 2,777,778 options (direct and indirect) for A$25,000.
- Paul Hopper acquired 2,777,778 shares and 2,777,778 options (indirect) for A$25,000.
- Riccardo Canevari acquired 3,888,889 shares and 3,888,889 options (direct) for A$35,000.
- All shares were acquired at A$0.009 per share; options have an exercise price of A$0.018 and expire July 31, 2029.
- No shares or options were disposed of by any director.
- The acquisitions were not made during a closed period.
Financial Impact
Total director consideration of A$110,000 for approximately 11.2 million shares at A$0.009/share. No company-level financial impact.
Risk Factors
- No material risks identified from this filing; the share issuance is small relative to director holdings.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-101968 |
| Document: ea0306179-6k_radiopharm.htm | 0001213900-26-101968 |
| Document: 0001213900-26-101968-index-headers.html | 0001213900-26-101968 |
| Document: 0001213900-26-101968-index.html | 0001213900-26-101968 |
| Document: 0001213900-26-101968.txt | 0001213900-26-101968 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | — | awaiting T+5 | — | — |
Oct 20, 2026 6d ago | 6-K | $0.9900 | awaiting T+5 | — | $0.9600 (−3.03%) |
Oct 14, 2026 11d ago | SC 13G | $1.08 $0.9500 | ▼ −12.04% | ▼ −11.02% | $0.9600 (−11.11%) |
Oct 5, 2026 21d ago | 6-K | $1.27 $1.11 | ▼ −12.60% | ▼ −13.02% | $0.9600 (−24.41%) |
Oct 1, 2026 25d ago | 6-K | $1.48 $1.11 | ▼ −25.00% | ▼ −26.30% | $0.9600 (−35.14%) |
Sep 30, 2026 26d ago | 6-K | $1.62 $1.15 | ▼ −29.01% | ▼ −30.93% | $0.9600 (−40.74%) |
Sep 24, 2026 4w ago | EFFECT | $1.57 $1.48 | ▲ +5.85% | ▲ +5.43% | $0.9600 (+38.93%) |
Sep 22, 2026 4w ago | 6-K | $1.65 $1.52 | ▼ −7.88% | ▼ −6.69% | $0.9600 (−41.82%) |
Sep 14, 2026 6w ago | 6-K | $2.01 $1.61 | ▼ −19.90% | ▼ −20.01% | $0.9600 (−52.24%) |
Sep 11, 2026 6w ago | 6-K | $1.98 $1.65 | ▼ −16.67% | ▼ −16.45% | $0.9600 (−51.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers